Discovery of 1<i>H</i>-Pyrazol-3(2<i>H</i>)-ones as Potent and Selective Inhibitors of Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK)
作者:Adrian L. Smith、Kristin L. Andrews、Holger Beckmann、Steven F. Bellon、Pedro J. Beltran、Shon Booker、Hao Chen、Young-Ah Chung、Noel D. D’Angelo、Jennifer Dao、Kenneth R. Dellamaggiore、Peter Jaeckel、Richard Kendall、Katja Labitzke、Alexander M. Long、Silvia Materna-Reichelt、Petia Mitchell、Mark H. Norman、David Powers、Mark Rose、Paul L. Shaffer、Michelle M. Wu、J. Russell Lipford
DOI:10.1021/jm5017494
日期:2015.2.12
The structure-based design and optimization of a novel series of selective PERK inhibitors are described resulting in the identification of 44 as a potent, highly selective, and orally active tool compound suitable for PERK pathway biology exploration both in vitro and in vivo.
Hajdu; Balog, 1959, vol. 4, p. 171,172
作者:Hajdu、Balog
DOI:——
日期:——
US4033945A
申请人:——
公开号:US4033945A
公开(公告)日:1977-07-05
US4137228A
申请人:——
公开号:US4137228A
公开(公告)日:1979-01-30
[EN] CARBAZOLE COMPOUNDS AND METHODS OF USING SAME<br/>[FR] COMPOSÉS CARBAZOLE ET LEURS MÉTHODES D'UTILISATION
申请人:OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOST YU PANACELA LABS
公开号:WO2015020553A1
公开(公告)日:2015-02-12
The present invention provides carbazole compounds of the formula (I), which can be used for treating microbial, protozoan, viral infections and cancer.